Trevi Therapeutics TRVI
NASDAQ TRVI
$14.59 +0.17 (+1.18%)
As of: Sep 30, 2026 · 10:25 AM EDT

Trevi Therapeutics (TRVI) Interest Coverage Ratio (2018 - 2022)

Updated

Trevi Therapeutics' (TRVI) Interest Coverage Ratio stood at -12881.00 in FY2024, compared with -86.76 in FY2023.

Analysis

Trevi Therapeutics (TRVI) Interest Coverage Ratio (2018 - 2022) Analysis & Trends

Starting with FY2018, Trevi Therapeutics' Interest Coverage Ratio history includes 6 years.

  • The FY2024 figure is the lowest annual Interest Coverage Ratio in data going back to FY2018.
  • Per Business Quant data, TRVI's Interest Coverage Ratio was -86.76 in FY2023, -25.72 in FY2022, -27.02 in FY2021 and -71.25 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.41
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 10.28
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 7.27
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 5.22
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -42.08
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Trevi Therapeutics 2.05 Bn 2.05 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -24.30
Sep 30, 2022 -28.78
Jun 30, 2022 -26.51
Mar 31, 2022 -23.26
Dec 31, 2021 -26.77
Sep 30, 2021 -22.93
Jun 30, 2021 -30.97
Mar 31, 2021 -27.51
Dec 31, 2020 -29.85
Sep 30, 2020 -48.95
Jun 30, 2018 -85.88
Mar 31, 2018 -25.54
API Access

Trevi Therapeutics Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=TRVI&period=max&api_key=YOUR_API_KEY